These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 33630809)
1. Comparison of 68Ga-FAPI and 18F-FDG PET/CT in the Imaging of Pancreatic Cancer With Liver Metastases. Deng M; Chen Y; Cai L Clin Nucl Med; 2021 Jul; 46(7):589-591. PubMed ID: 33630809 [TBL] [Abstract][Full Text] [Related]
2. Comparison of 18F-FDG, 68Ga-FAPI, and 68Ga-DOTATATE PET/CT in a Patient With Pancreatic Neuroendocrine Tumor. Cheng Z; Zou S; Cheng S; Song S; Zhu X Clin Nucl Med; 2021 Sep; 46(9):764-765. PubMed ID: 34132674 [TBL] [Abstract][Full Text] [Related]
3. Tumor Imaging With 68Ga-DOTA-FAPI-04 PET/CT: Comparison With 18F-FDG PET/CT in 22 Different Cancer Types. Çermik TF; Ergül N; Yılmaz B; Mercanoğlu G Clin Nucl Med; 2022 Apr; 47(4):e333-e339. PubMed ID: 35085165 [TBL] [Abstract][Full Text] [Related]
4. 68Ga-FAPI PET/CT Imaging of Multiple Muscle Metastases of Pancreatic Cancer. Gong W; Yang X; Wu J; Ou L; Zhang C Clin Nucl Med; 2022 Jan; 47(1):73-75. PubMed ID: 34874351 [TBL] [Abstract][Full Text] [Related]
5. Comparison of 18F-FDG PET/CT and 68Ga-FAPI-04 PET/CT in the staging and restaging of gastric adenocarcinoma. Gündoğan C; Kömek H; Can C; Yildirim ÖA; Kaplan İ; Erdur E; Poyraz K; Güzel Y; Oruç Z; Çakabay B Nucl Med Commun; 2022 Jan; 43(1):64-72. PubMed ID: 34661379 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the diagnostic efficacy of Zhang Z; Jia G; Pan G; Cao K; Yang Q; Meng H; Yang J; Zhang L; Wang T; Cheng C; Zuo C Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2877-2888. PubMed ID: 35243518 [TBL] [Abstract][Full Text] [Related]
8. Superiority of 68Ga-FAPI-04 in Delineation of Soft Tissue and Liver Metastases in Chromophobe Renal Cell Carcinoma for Restaging. Xie F; Fu L; Zhou W Clin Nucl Med; 2022 Dec; 47(12):e758-e759. PubMed ID: 36342807 [TBL] [Abstract][Full Text] [Related]
9. The additional role of [68Ga]Ga-FAPI-04 PET/CT in patients with unknown primary lesion with a negative or equivocal [18F]FDG. Shu Q; Deng M; Hu M; Liu M; Chen X; Chen Y; Cai L Eur J Nucl Med Mol Imaging; 2023 Apr; 50(5):1442-1452. PubMed ID: 36609606 [TBL] [Abstract][Full Text] [Related]
10. Positron emission tomography and computed tomography with [ Pang Y; Zhao L; Shang Q; Meng T; Zhao L; Feng L; Wang S; Guo P; Wu X; Lin Q; Wu H; Huang W; Sun L; Chen H Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1322-1337. PubMed ID: 34651226 [TBL] [Abstract][Full Text] [Related]
11. 68Ga-FAPI PET/CT Detected Non-FDG-Avid Gastric Stromal Tumor. Qiu L; Lan L; Liu H; Deng J; Chen Y Clin Nucl Med; 2022 Mar; 47(3):226-227. PubMed ID: 34392281 [TBL] [Abstract][Full Text] [Related]
12. Intense FAPI Uptake in Inflammation May Mask the Tumor Activity of Pancreatic Cancer in 68Ga-FAPI PET/CT. Luo Y; Pan Q; Zhang W; Li F Clin Nucl Med; 2020 Apr; 45(4):310-311. PubMed ID: 31977474 [TBL] [Abstract][Full Text] [Related]
13. Imaging fibroblast activation protein in liver cancer: a single-center post hoc retrospective analysis to compare [ Guo W; Pang Y; Yao L; Zhao L; Fan C; Ke J; Guo P; Hao B; Fu H; Xie C; Lin Q; Wu H; Sun L; Chen H Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1604-1617. PubMed ID: 33179149 [TBL] [Abstract][Full Text] [Related]
14. 18F-FDG PET/CT and 68Ga-FAPI-4 PET/CT Findings of Bilateral Knee Osteoarthritis in a Patient With Uveal Malignant Melanoma. Erol Fenercioğlu Ö; Beyhan E; Ergül N; Arslan E; Çermik TF Clin Nucl Med; 2022 Feb; 47(2):e144-e146. PubMed ID: 34319962 [TBL] [Abstract][Full Text] [Related]
15. 68Ga-FAPI and 18F-PET/CT Images in Intestinal Tuberculosis. Zheng J; Lin K; Zheng S; Yao S; Miao W Clin Nucl Med; 2022 Mar; 47(3):239-240. PubMed ID: 34619704 [TBL] [Abstract][Full Text] [Related]
16. Comparison of 68Ga-FAPI and 18F-FDG PET/CT in Dermatofibrosarcoma Protuberans. Wu J; Zhang S; Rao Z; Wang Y; Zhang C Clin Nucl Med; 2022 Jul; 47(7):629-631. PubMed ID: 35452009 [TBL] [Abstract][Full Text] [Related]
17. Comparison of PET imaging of activated fibroblasts and Shi X; Xing H; Yang X; Li F; Yao S; Congwei J; Zhao H; Hacker M; Huo L; Li X Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1593-1603. PubMed ID: 33097975 [TBL] [Abstract][Full Text] [Related]
18. A Head-to-Head Comparison of 68Ga-LNC1007 and 2-18F-FDG/68Ga-FAPI-02 PET/CT in Patients With Various Cancers. Zang J; Lin R; Wen X; Wang C; Zhao T; Jakobsson V; Yang Y; Wu X; Guo Z; Chen X; Zhang J; Miao W Clin Nucl Med; 2023 Oct; 48(10):861-868. PubMed ID: 37682601 [TBL] [Abstract][Full Text] [Related]
19. Comparison of [ Chen H; Pang Y; Wu J; Zhao L; Hao B; Wu J; Wei J; Wu S; Zhao L; Luo Z; Lin X; Xie C; Sun L; Lin Q; Wu H Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1820-1832. PubMed ID: 32222810 [TBL] [Abstract][Full Text] [Related]
20. The potential role of 68Ga-FAPI-04 PET/CT for screening malignancy in suspected colonic lesions. Erol Fenercioğlu Ö; Beyhan E; Şahin R; Baloğlu MC; Arslan E; Çermik TF; Ergül N Nucl Med Commun; 2023 Oct; 44(10):896-899. PubMed ID: 37450605 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]